New ALS drug
(`Motor Neuron Disease` or `MND` also known as `Lou Gehrig's disease`)
You can edit text on your website by double clicking on a text box on your website. Alternatively, when you select a 
A previously unknown problem protein has been discovered
A specifically designed new ALS drug, RCH4, successfully suppresses it
 ​RCH4 is available free of charge on compassionate basis depending on availability and location

        Family treatment with RCH4
          Life extension in familial cases

By end 2017 there were three familial cases in total. We can demonstrate that there is a relationship between ALS and FTD - referenced in the lower "Family of four" case above. These examples indicate that the outlook can be positive.​​​
Unless where indicated otherwise, treatment is ongoing at time of publication.​​
It cannot be assumed that all familial cases will respond with the same efficacy.
No claims of efficacy are made nor is any interpretation of data offered.

Data source: Patients own monthly monitoring reports
Certain information in some of the above charts has been changed to avoid possible public indntification of the patients.